Streetbeat News

Legal

TSLA

The National Highway Traffic Safety Administration (NHTSA) has initiated an investigation into Tesla Inc's (NASDAQ:TSLA) software update intended to address issues with the Autosteer feature in over 2 million vehicles recalled in December. The probe follows concerns arising from post-remedy crash events and preliminary test results of the updated vehicles.

Portfolio Pulse from Anan Ashraf

April 26, 2024 | 10:19 am

AMZN

The FTC has accused Amazon.com Inc. (NASDAQ:AMZN) executives, including Jeff Bezos and CEO Andy Jassy, of deleting text messages that could serve as evidence in an antitrust investigation. The executives allegedly used Signal for communication between April 2019 and May 2022, with messages set to disappear. Amazon refuted the claims, stating it had disclosed its use of Signal and collected conversations from employees' phones for the FTC.

Portfolio Pulse from Ananya Gairola

April 26, 2024 | 5:43 am

ABNB

AMD

AMZN

ASML

GOOG

META

NVDA

Nationwide pro-Palestine protests at U.S. universities have led to hundreds of arrests, with students demanding divestment from companies benefiting from Israel's actions in Gaza and the West Bank. Companies like Alphabet (GOOG), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), ASML Holding (ASML), Boeing (BA), Amazon.com (AMZN), and Airbnb (ABNB) are mentioned in relation to these divestment calls. The protests aim to pressure Israel into a cease-fire and have sparked significant controversy and media attention.

Portfolio Pulse from Natan Ponieman

April 25, 2024 | 9:12 pm

LIVN

LivaNova PLC (NASDAQ:LIVN) announced a cybersecurity incident affecting its U.S. subsidiary, LivaNova USA, Inc., which led to unauthorized access to U.S. patients' personal information. The breach, initially disclosed on November 20, 2023, was detected on November 19, 2023, with unauthorized access dating back to October 26, 2023. The compromised data includes names, contact details, Social Security numbers, medical and health insurance information. LivaNova is offering affected patients complimentary identity protection and credit monitoring services.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 8:23 pm

JOANQ

Joann Inc. has received court approval for its prepackaged recapitalization plan, a significant step in restructuring its finances. This approval will allow Joann to reorganize its debt and equity structure, aiming to improve its financial health and operational efficiency.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 8:21 pm

BNTX

PFE

Pfizer and BioNTech shares are trading lower following reports that GSK is suing them for patent infringement related to the mRNA technology used in their COVID-19 vaccines.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 7:34 pm

NTDOY

Nintendo ADR (OTC:NTDOY) has issued takedown notices to Facepunch Studios, the developers of Garry's Mod, demanding the removal of Nintendo-related content from the game. This action affects content accumulated over nearly two decades. The enforcement of intellectual property rights by Nintendo has been consistent, as seen in previous actions against emulator projects like Dolphin and Yuzu. The removal of Nintendo-themed content from Garry's Mod represents a significant change for the game, which has included such content since its inception.

Portfolio Pulse from Franca Quarneti

April 25, 2024 | 7:22 pm

ETHUSD

Consensys is suing the SEC to affirm Ethereum's status as a non-security, arguing the SEC's overreach could stifle innovation and misclassify Ethereum's ecosystem. The lawsuit seeks to protect Ethereum and its developers from being regulated as securities, emphasizing the need for regulatory clarity and industry support.

Portfolio Pulse from Murtuza Merchant

April 25, 2024 | 6:48 pm

BNTX

GSK

PFE

GSK Plc has filed a lawsuit against Pfizer Inc and BioNTech SE in a Delaware federal court, alleging patent infringement over mRNA technology used in COVID-19 vaccines. GSK claims Pfizer and BioNTech's Comirnaty vaccines infringe on its patents, seeking unspecified damages and ongoing licensing fees. Pfizer and BioNTech are set to defend their intellectual property, while GSK is open to licensing the patents. This legal battle is part of a series involving Pfizer, BioNTech, and Moderna over vaccine technology patents. Additionally, GSK previously sued Pfizer over its RSV vaccine, alleging infringement on its patents. Stock prices for PFE, GSK, and BNTX have been affected, with PFE down 3.48%, GSK down 0.09%, and BNTX down 1.50%.

Portfolio Pulse from Vandana Singh

April 25, 2024 | 5:51 pm

CAH

The FDA has criticized Cardinal Health for not ensuring that syringes included in their convenience kits have the necessary 510(k) clearance, which has hindered the FDA's ability to assess associated risks. This oversight could impact the company's operations and regulatory compliance.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 5:12 pm